Schonfeld Strategic Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Sell |
389,066
-211,101
| -35% | -$986K | 0.01% | 958 |
|
|
2025
Q1 | $3.29M | Buy |
600,167
+497,167
| +483% | +$2.73M | 0.02% | 610 |
|
|
2024
Q4 | $349K | Sell |
103,000
-69,327
| -40% | -$235K | ﹤0.01% | 1486 |
|
|
2024
Q3 | $491K | Sell |
172,327
-163,720
| -49% | -$467K | ﹤0.01% | 1306 |
|
|
2024
Q2 | $756K | Buy |
336,047
+45,549
| +16% | +$102K | ﹤0.01% | 1198 |
|
|
2024
Q1 | $642K | Buy |
+290,498
| New | +$642K | ﹤0.01% | 1213 |
|
|
2023
Q3 | – | Sell |
-25,800
| Closed | -$67.6K | – | 2152 |
|
|
2023
Q2 | $67.6K | Buy |
+25,800
| New | +$67.6K | ﹤0.01% | 1683 |
|
|
2022
Q2 | – | Sell |
-12,500
| Closed | -$32K | – | 2939 |
|
|
2022
Q1 | $32K | Buy |
+12,500
| New | +$32K | ﹤0.01% | 2304 |
|